Muutke küpsiste eelistusi

Managerial Epidemiology Cases and Concepts 3rd Revised edition [Kõva köide]

3.75/5 (16 hinnangut Goodreads-ist)
  • Formaat: Hardback, 1 pages, kõrgus x laius x paksus: 254x177x43 mm, kaal: 1384 g
  • Sari: AUPHA/HAP Book
  • Ilmumisaeg: 01-Dec-2015
  • Kirjastus: Health Administration Press
  • ISBN-10: 1567936849
  • ISBN-13: 9781567936841
Teised raamatud teemal:
Managerial Epidemiology Cases and Concepts 3rd Revised editionSuurem pilt
  • Formaat: Hardback, 1 pages, kõrgus x laius x paksus: 254x177x43 mm, kaal: 1384 g
  • Sari: AUPHA/HAP Book
  • Ilmumisaeg: 01-Dec-2015
  • Kirjastus: Health Administration Press
  • ISBN-10: 1567936849
  • ISBN-13: 9781567936841
Teised raamatud teemal:
Püsilink: https://www.kriso.ee/db/9781567936841.html
Märksõnad:

Instructor Resources: PowerPoint slides and answers to capstone case studies.

60 New Cases Included!

Fifteen new in-depth capstone cases expand on concepts covered in the book. The capstone cases can be used as problem sets or exams, or they can form the foundation for a case-study approach to classroom instruction. Answers to the capstone cases are stored in a secure page in the online Instructor’s Resources for this book. In-chapter cases are accompanied by in-chapter answer guides. These case/ answer guide combinations are presented as an integral component of the learning process offered by the book. By working through the cases, using the answer guides, students will learn new material and gain application reinforcement of concepts presented elsewhere in the chapters. End-of-chapter cases provide additional exercises for application practice. Answers are provided at the end of the book so that students can self-quiz and use the cases to build their understanding of epidemiology.

Preface xix
Part I Concepts, Principles, and Applications 1(196)
Chapter 1 An Introduction to Managerial Epidemiology
3(16)
Steven T. Fleming
Thomas Tucker
F. Douglas Scutchfield
Case Study 1.1. Group Health East
7(11)
References
18(1)
Chapter 2 Infectious Disease Epidemiology
19(30)
Glyn G. Caldwell
Steven T. Fleming
Agent, Host, and Environment
20(4)
Transmission
24(4)
Prevention
28(5)
Case Study 2.1. Food Poisoning Outbreak at Bluegrass Hospital
31(2)
Epidemic Investigation
33(8)
Case Study 2.2. Outbreak of Influenza in a New York Nursing Home
39(2)
Summary
41(1)
End-of-Chapter Case Exercises
42(1)
References
43(6)
Chapter 3 Measuring and Interpreting Morbidity
49(26)
Steven T. Fleming
F. Douglas Scutchfield
Population Health
49(1)
The Nature and Definition of Disease
50(1)
Natural History of Disease
51(2)
Sources of Morbidity Data
53(1)
Measuring Morbidity
54(5)
Case Study 3.1. Product Lines for Group Health East
57(2)
Screening
59(11)
Case Study 3.2. Breast Cancer Screening
62(4)
Case Study 3.3. Prostate Cancer Screening
66(4)
Summary
70(1)
End-of-Chapter Case Exercises
70(2)
References
72(3)
Chapter 4 Healthcare Planning and Needs Assessment
75(32)
Steven T. Fleming
F. Douglas Scutchfield
Joel Lee
Community Health Planning Tools and Benchmarks
78(8)
Case Study 4.1. Eastern Kentucky Health
84(2)
Institutional Planning
86(6)
Case Study 4.2. Determining Bed Demand for Cardiac Patients Age 65-84
88(4)
A Strategic Planning Model
92(2)
Marketing
94(2)
Needs Assessment
96(2)
Human Resources Planning
98(3)
Summary
101(1)
End-of-Chapter Case Exercises
102(1)
References
103(4)
Chapter 5 Quality of Care Measurement
107(30)
Steven T. Fleming
Sarah Wackerbarth
Epidemiology and Quality
109(2)
Rates and Surveillance
111(4)
Case Study 5.1. MRSA Surveillance at University Hospital
113(2)
Outcomes of Care—Complication Rates
115(5)
Case Study 5.2. Risk-Adjusted Complication Rates in a Small Rural Hospital
118(2)
Managed Care
120(1)
Avoidable Hospitalizations
120(2)
Quality Indicators
122(5)
Case Study 5.3. Inpatient Quality of Care Indicators for Bluegrass Hospital
124(3)
Total Quality Management
127(5)
Summary
132(1)
End-of-Chapter Case Exercises
133(1)
References
134(3)
Chapter 6 Mortality and Risk Adjustment
137(34)
Steven T. Fleming
F. Douglas Scutchfield
Measuring Mortality with Rates
139(1)
Comparing Mortality Across Time, Place, and Person
140(10)
Case Study 6.1. Breast Cancer Mortality Rates and Migration
147(3)
Standardization of Mortality Rates
150(5)
Case Study 6.2. Age and Gender Adjustment in Two Managed Care Organizations
152(3)
Risk-Adjusted Mortality Rates
155(10)
Case Study 6.3. Risk Adjustment with Contingency Tables—State of Pennsylvania
160(3)
Case Study 6.4. Risk Adjustment with Multivariate Techniques—State of New York
163(2)
Summary
165(1)
End-of-Chapter Case Exercises
166(3)
References
169(2)
Chapter 7 Descriptive Epidemiology: Person, Place, Time
171(26)
Steven T. Fleming
Jeffery Jones
Descriptive Epidemiology: The Person
171(8)
Case Study 7.1. Infant Mortality Disparities by Race
175(4)
Descriptive Epidemiology: Place
179(1)
Spot Maps
179(2)
Clusters
181(1)
Geographic Information Systems
182(8)
Case Study 7.2. HIV Clinics in Kentucky
187(3)
Descriptive Epidemiology: Time
190(2)
Summary
192(1)
End-of-Chapter Case Exercises
193(2)
References
195(2)
Part II Epidemiology and Finance 197(64)
Chapter 8 Epidemiology and Financial Management
199(32)
Keith E. Boles
Steven T. Fleming
Healthcare Delivery: Reactive or Proactive?
199(2)
Healthcare Risks
201(2)
The Role of Epidemiology in Finance
203(2)
Capitation: An Introduction
205(3)
Capitation Basics
208(2)
Risk Adjustment: The Basics
210(7)
Case Study 8.1. Incorporating Health Risks into Capitation Rates
214(3)
Adjusting Capitation Rates
217(7)
Case Study 8.2. Group Health East: Risk Factors and Capitation Rates
220(4)
Pay for Performance
224(1)
Breakeven Analysis
225(2)
Summary
227(1)
End-of-Chapter Case Exercises
227(1)
References
228(3)
Chapter 9 Cost-Effectiveness Analysis
231(30)
Steven T. Fleming
Cost-Effectiveness Ratios
232(1)
Cost-Effectiveness Model
232(1)
Program Specification
233(1)
Measuring Effectiveness
234(1)
Quality-Adjusted Life Years
235(4)
Case Study 9.1. The Oregon Medicaid Prioritization of Health Services Program
238(1)
Biased Estimates
239(1)
Measuring Costs
240(4)
Cost—Benefit Analysis
244(1)
Choosing Among Programs
245(2)
Uncertainty
247(4)
Case Study 9.2. Cost-Effectiveness of Health Insurance
248(3)
Summary
251(6)
Case Study 9.3. CEA for Targeted or Universal Prostate Cancer Testing
252(5)
End-of-Chapter Case Exercises
257(2)
References
259(2)
Part III Evidence-Based Management And Medicine 261(150)
Chapter 10 Statistical Tools
265(18)
Mary Kay Rayens
Thomas C. Tucker
Descriptive and Analytical Epidemiology
265(1)
Levels of Measurement
266(1)
Sampling
266(1)
Descriptive Statistics for Continuous Variables
267(4)
Descriptive Statistics for Categorical Variables
271(1)
Inferential Statistics
272(5)
z Test for Differences in Proportions
277(1)
Confidence Intervals
278(2)
Multivariate Models
280(1)
Summary
281(1)
End-of-Chapter Case Exercises
281(1)
References
282(1)
Additional Readings
282(1)
Chapter 11 Case—Control Studies
283(30)
Steven T. Fleming
Selection of Cases and Controls
284(1)
Exposure
285(1)
Relative Risk in a Case—Control Study
286(2)
Confounding
288(4)
Case Study 11.1. Coffee and Pancreatic Cancer
292(1)
Sources of Bias
292(13)
Case Study 11.2. Smoking and Low Birth Weight Newborns
299(4)
Case Study 11.3. Fen-Phen and Primary Pulmonary Hypertension
303(2)
Cross-Sectional Studies
305(1)
Case—Control Advantages and Disadvantages
306(1)
Summary
307(1)
End-of-Chapter Case Exercises
307(2)
References
309(4)
Chapter 12 Cohort Studies
313(28)
John N. Lewis
Steven T. Fleming
Selection of Cohorts
316(1)
Exposure
317(4)
Relative Risk in a Cohort Study
321(2)
Case Study 12.1. Scottish Heart Study
322(1)
Measures of Disease Burden
323(3)
Case Study 12.2. The Unknown Cohort Study
324(2)
Measuring Incidence
326(5)
Case Study 12.3. Smoking, Heart Disease, and Lung Cancer
328(3)
Case—Control and Cohort Studies
331(3)
Case Study 12.4. Smoking and Prostate Cancer
333(1)
Survey Methodology
334(1)
Advantages and Disadvantages
335(1)
Summary
335(1)
End-of-Chapter Case Exercises
336(2)
References
338(3)
Chapter 13 Randomized Clinical Trials
341(32)
Steven T. Fleming
Randomization
343(2)
Historical Controls and Crossover Studies
345(1)
Methods of Randomized Clinical Trials
346(1)
Sample Size
346(3)
Duration and Masking
349(1)
Integrity of the Randomization
350(3)
Ethical Considerations
353(3)
Case Study 13.1. The RAND Health Insurance Experiment
354(2)
Factorial Design
356(6)
Case Study 13.2. Vitamin E and n-3 Polyunsaturated Fatty Acids After Myocardial Infarction
357(4)
Case Study 13.3. Inpatient Staffing at Henry Ford Hospital
361(1)
Meta-analysis
362(2)
Community Trials, Cluster Randomization, and Ecological Studies
364(2)
Summary
366(1)
End-of-Chapter Case Exercises
367(2)
References
369(4)
Chapter 14 Clinical Epidemiology and Decision Making
373(38)
Kevin A. Pearce
Steven T. Fleming
F. Douglas Scutchfield
Experience and Tradition in Medical Practice
374(1)
The Evidence Base of Clinical Practice
375(5)
The Clinical Encounter
380(7)
Clinical-Encounter Vignette Part I: Making a Diagnosis for a Patient Presenting with Chest Pain
381(4)
Clinical-Encounter Vignette Part II: Treatment Options for a Patient Diagnosed with GERD
385(2)
Prevention
387(5)
Clinical-Encounter Vignette Part III: Prevention and Control Strategies
389(3)
Cost-Effectiveness and the Number Needed to Treat
392(2)
Clinical-Encounter Vignette Part IV: Family History and Number Needed to Treat
393(1)
The Future
394(11)
Case Study 14.1. Clinical Decision-Making Toolbox
397(8)
End-of-Chapter Case Exercises
405(2)
References
407(4)
Part IV Applications of Epidemiology to Specific Diseases 411(122)
Chapter 15 Cardiovascular Disease
413(32)
Steven R. Browning
Steven T. Fleming
The Epidemiology of CVD
414(1)
Trends in CVD Mortality
415(3)
The Geographic Distribution of CVD
418(3)
The Biology of CVD and Risk Factors
421(3)
Managerial and Economic Considerations with Screening
424(7)
Case Study 15.1. Screening for CAC
427(4)
Other Considerations for Screening Tests
431(1)
Cost-Effectiveness of CAC Screening
432(5)
Case Study 15.2. Cost-Effectiveness of Gastric Bypass for Severe Obesity
433(4)
Strategies for the Prevention of CVD
437(1)
Conclusion
438(1)
Acknowledgments
439(1)
End-of-Chapter Case Exercises
439(1)
References
440(5)
Chapter 16 Human Immunodeficiency Virus Infection
445(22)
H. Irene Hall
Kathleen McDavid Harrison
Steven T. Fleming
Diagnoses
446(2)
Prevalence
448(2)
Mortality
450(1)
Screening and Diagnostic Tests
451(4)
Case Study 16.1. HIV-1 Enzyme Immunoassay for HIV
452(3)
Prevention and Control Measures
455(1)
Measures of Quality of Care
456(1)
Study Designs Used to Examine Risk Factors
456(1)
Summary
457(4)
Case Study 16.2 Cost-Effectiveness of HIV Screening
457(4)
End-of-Chapter Case Exercises
461(1)
References
462(5)
Chapter 17 Alzheimer's Disease
467(42)
Suzanne L. Tyas
Iris Gutmanis
Introduction to Alzheimer's Disease
468(5)
Impact of Alzheimer's Disease
473(8)
Case Study 17.1. Alzheimer's Disease Incidence, Prevalence, and Mortality
480(1)
Diagnosis and Detection
481(6)
Case Study 17.2. Screening for Cognitive Impairment: The Mini-Mental State Examination
484(3)
Management and Care
487(4)
Challenges to the Epidemiologic Study of Alzheimer's Disease
491(2)
Summary
493(4)
Case Study 17.3 Study Designs and Measures of Association (Example: Smoking and Alzheimer's Disease)
494(3)
End-of-Chapter Case Exercises
497(1)
References
498(11)
Chapter 18 Epidemiology and Leadership
509(24)
Steven T. Fleming
James W. Holsinger Jr
Introduction
509(1)
Definitions and Distinctions
510(1)
The Role of Epidemiology in Defining Leadership
511(2)
Epidemiology and the Science and Art of Leadership
513(2)
Epidemiology and Evidence-Based Medicine, Management, and Public Health
515(4)
What Is the Evidence?
519(3)
Systems Thinking and Public Health Leadership
522(2)
Complex Adaptive Systems and Public Health Leadership
524(3)
Summary Case Study: Back to the Future
527(1)
Summary
527(1)
References
528(5)
Capstone Cases 533(130)
Capstone Case A: Hepatitis A Outbreak in the Midwest
534(16)
Capstone Case B: Cardiovascular Disease
550(8)
Capstone Case C: Colorectal Cancer Screening
558(9)
Capstone Case D: Needs Assessment for Stroke Services
567(7)
Capstone Case E: Quality of Care in Seven Boston Hospitals
574(17)
Capstone Case F: Mortality in Kentucky: A Comparison of Jefferson and Fayette Counties
591(10)
Capstone Case G: Changes in Non-Group Coverage Under the Affordable Care Act
601(8)
Capstone Case H: Cost-Effectiveness Analysis of Type II Diabetes
609(8)
Capstone Case I: Sleep Duration and Cardiovascular Disease: A Cross-Sectional Study
617(4)
Capstone Case J: Obesity and Endometrial Cancer: Case Control and Prospective Cohort Studies
621(6)
Capstone Case K: Vitamin E, Selenium, and Prostate Cancer: A Randomized Clinical Trial
627(5)
Capstone Case L: Abortion and Breast Cancer: Confounding, Bias, and Effect Modification
632(10)
Capstone Case M: Clinical Decision Making: Acute Appendicitis in Kids
642(6)
Capstone Case N: Flemington Village
648(4)
Capstone Case O: Using Leadership and Managerial Epidemiology to Lead a Hospital Through Crisis
652(11)
Answers for End-of-Chapter Case Exercises 663(20)
Glossary 683(10)
Appendix 693(4)
Index 697(28)
About the Contributors 725(4)
About the Editor 729